findmyKOL

John Sheppard, MD

Enriched profile

President, Virginia Eye Consultants; Professor of Ophthalmology, Microbiology, and Molecular Biology, Eastern Virginia Medical School · Virginia Eye Consultants

ORCIDNPI
Region🇺🇸 Norfolk, VA · Southeast · United StatesSpecialtyOphthalmologyFocusOcular Surface and Contact Lens+4
Active KOLLatest publicationSee ScholarshipOnline presenceverified 2026Payments2021–2025NIH funding2004–2010Why? →

John Sheppard is President, Virginia Eye Consultants; Professor of Ophthalmology, Microbiology, and Molecular Biology, Eastern Virginia Medical School at Virginia Eye Consultants. OpenAlex indexes 199 publications with 5,162 citations (h-index 38); ClinicalTrials.gov lists 8 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

John Sheppard, M.D., is President, Virginia Eye Consultants. The public record shows 199 publications with 5,162 citations (h-index 38), centered on Ocular Surface and Contact Lens, Ocular Infections and Treatments, Corneal Surgery and Treatments. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 42 companies, 3 NIH-funded awards (2004–2010).

  • Top research focus: Ocular Surface and Contact Lens
  • 8 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 42 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Dry Eye / Uveitis4 trialsConjunctivitis2 trialsKeratoconjunctivitis2 trialsUveitis2 trialsUveitis, Anterior2 trialsDry Eye Syndromes2 trialsCorneal Neovascularization1 trialKeratoconjunctivitis Sicca1 trialBlepharitis1 trialGlaucoma

Research focus

OpenAlex concept fingerprint
Ocular Surface and Contact LensOcular Infections and TreatmentsCorneal Surgery and TreatmentsGlaucoma and retinal disordersOcular Diseases and Behçet’s Syndrome

Drugs & molecules

across trials, industry payments and publications
Xiidrageneric · LifitegrastClinical trialsIndustry payments173Publications1Cequageneric · CyclosporineClinical trialsIndustry payments32Publications3Eysuvisgeneric · Loteprednol etabonateClinical trialsIndustry payments11Publications2

Works with

trial sponsors and companies reporting payments
Kala Pharmaceuticals, Inc.Clinical trials1Industry payments5Bausch & Lomb Americas Inc.Clinical trialsIndustry payments302Mallinckrodt Hospital Products Inc.Clinical trialsIndustry payments241

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
199publications

Distinct works indexed by OpenAlex, matched via ORCID.

5,162citations

Total citations across indexed works.

38h-index

Hirsch index (OpenAlex). i10-index 100.

Clinical & industry

trials, payments and federal funding
8clinical trials

Investigator role on registered studies.

View trials
42companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
3NIH grants · 2004–2010

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

42 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    57%
    Corticosteroid14%
    Prednisolone Acetate89%Fluorometholone6%Dexamethasone Sodium Phosphate5%
    Part D251 patients
    alpha-Adrenergic Agonist11.2%
    Brimonidine Tartrate63%Alphagan P19%Combigan11%Brimonidine Tartrate-Timolol8%
    Part D123 patients
  • Anti-infectives

    13.2%
    Fluoroquinolone Antibacterial7.2%
    Moxifloxacin100%
    Part D116 patients
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor3.8%
    Valacyclovir100%
    Part D45 patients
  • Cancer & immunology

    10.2%
    Calcineurin inhibitor9.7%
    Restasis65%Cyclosporine35%
    Part D132 patients
    TNF inhibitor0.5%
    Humira(Cf) Pen100%
    Part D<11 patients
6 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)9.1% facility · 90.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

3 NIH research awards on record, funded 20042010 per NIH RePORTER. The latest:

Publications

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Frank A. Lattanzio23Patricia B. Williams22S. S. Samudre15

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/john-sheppard-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • ResearchGate

    researchgate.net/profile/John-Sheppard-3

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.D.

    Brown University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →virginiaeyeconsultants.com
  • M.M.Sc.

    Brown University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →virginiaeyeconsultants.com
  • B.S.

    Brown University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →virginiaeyeconsultants.com
  • verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →virginiaeyeconsultants.com

Editorial & leadership roles

journal and society appointments
6 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record
1 more award behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Professor of Ophthalmology

    Microbiology, and Molecular Biology, Eastern Virginia Medical School

    1989
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →virginiaeyeconsultants.com
  • Research Director

    Ophthalmology Residency Program, Eastern Virginia Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →virginiaeyeconsultants.com
  • Clinical Director

    Thomas R. Lee Center for Ocular Pharmacology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →virginiaeyeconsultants.com
1 more affiliation behind the reveal.Reveal →

Media & interviews

press, podcasts and appearances
1 more media item behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.